Page 55 - Critical Path News Today

Toronto, ON (PRWEB) October 03, 2022 -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical

The Critical Path for Rare Neurodegenerative Diseases (CP-RND) partnership was launched to develop breakthrough treatments for neurodegenerative diseases.

Toronto, ON (PRWEB) September 21, 2022 -- In today’s patient-driven and competitive drug development landscape, healthcare organizations and related clinical

This Week in Washington: Congress Focuses on FDA User Fee Legislation, Telehealth and Continuing Resolution; Administration Issues Executive Order on Biomanufacturing.

Lawmakers are still working to hammer out a deal to reauthorize FDA user fee programs, with negotiations slated to continue into the weekend.

The US FDA and NIH have unveiled a public-private partnership (PPP) to understand and develop treatments for neurodegenerative diseases.

BioPharma

/PRNewswire/ -- Critical Path Institute (C-Path) has announced it will serve as the convener of the Critical Path for Rare Neurodegenerative Diseases (CP-RND),...

/PRNewswire/ -- Today, the U.S. Food and Drug Administration and the National Institutes of Health (NIH) announced the launch of the Critical Path for Rare...

SAN FRANCISCO, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Paubox, a leading provider of HIPAA compliant email and marketing solutions for healthcare...